“…One of the problems associated with internal in vivo dosimetry in brachytherapy, which is characterised by a high dose gradient, is the size of the detector. It must be: (1) of small size to minimise the effects of dose averaging detection on a volume as much as possible, and (2) compatible with the thin interstitial catheters of the most common brachytherapy applications including prostate [ 8 , 9 ], vaginal-cuff brachytherapy (VCBT), and other gynaecological sites such as cervical cancer [ 10 , 11 , 12 ]. The use of different in vivo dosimetry systems such as inorganic scintillator detectors, plastic scintillator detectors (PSD), and microMOSFET among others, has been extensively described [ 9 , 11 , 12 , 13 ].…”